Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Imaging Studies IV: Magnetic Resonance Imaging01:27

Imaging Studies IV: Magnetic Resonance Imaging

319
Introduction:Magnetic Resonance Imaging, or MRI, can include a specialized imaging technique of the urinary system known as Magnetic Resonance Urography (MRU). This radiation-free technique uses strong magnetic fields and radio waves to produce detailed images with the help of a computer. MRU is particularly effective for visualizing fluid-filled structures like the kidneys, ureters, and bladder.Applications of MRI in the Genitourinary SystemKidneys and Ureters: MRI detects tumors, cysts,...
319
Imaging Studies III: Computed Tomography01:27

Imaging Studies III: Computed Tomography

490
DefinitionComputed Tomography (CT) of the genitourinary (GU) tract is a non-invasive imaging modality that utilizes X-rays and computer processing to generate detailed cross-sectional images of the urinary system, encompassing the kidneys, ureters, bladder, and adjacent structures such as the adrenal glands.PurposeCT scans of the GU tract serve several diagnostic and therapeutic purposes, including:Diagnosis of Urinary Tract Diseases: Detects kidney stones, tumors, cysts, and congenital...
490
Imaging Studies V: Intravenous Urography and Retrograde Pyelography01:22

Imaging Studies V: Intravenous Urography and Retrograde Pyelography

2.0K
IntroductionIntravenous Urography (IVU) and Retrograde Pyelography (RP) are important diagnostic imaging techniques used to evaluate the urinary system. These methods help identify structural abnormalities, obstructions, and functional issues in the kidneys, ureters, and bladder. Both procedures use iodine-based contrast media to enhance the visibility of urinary tract structures on X-ray images, though they differ in their methods and indications.1. Intravenous Urography (IVU)Intravenous...
2.0K
Imaging Studies II: Positron Emission Tomography and Scintigraphy01:25

Imaging Studies II: Positron Emission Tomography and Scintigraphy

668
Positron Emission Tomography (PET) is a medical imaging technique that provides crucial insights into the body's physiological functions at a molecular level. It is an indispensable resource for diagnosing, staging, and monitoring various illnesses, notably cancer, neurological disorders, and cardiovascular conditions.
Fundamental Principles of PET
668
Radiological Investigation III: Pulmonary Angiogram and PET Scan01:13

Radiological Investigation III: Pulmonary Angiogram and PET Scan

531
Radiological investigations are paramount in the diagnosis and management of various pulmonary diseases. Two essential investigations are the Pulmonary Angiogram and the Positron Emission Tomography (PET) Scan.
Pulmonary Angiogram
A Pulmonary Angiogram is an invasive procedure involving injecting a contrast medium through a catheter threaded into the pulmonary artery or the right side of the heart to visualize the pulmonary vasculature. Computed Tomography (CT) scans have mainly replaced this...
531

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Genetic testing in prostate cancer-what the new S3 guideline means for urological practice].

Urologie (Heidelberg, Germany)·2026
Same author

Diagnostic accuracy and outcomes of lymph node staging in intermediate-risk prostate cancer.

BJU international·2026
Same author

The Pelvic Rosetta Classification Project: An Interdisciplinary Proposal for a Lymph Node Map of the Pelvis in Prostate Cancer.

Journal of nuclear medicine : official publication, Society of Nuclear Medicine·2025
Same author

PSMA PET Evaluation with a Deep Learning Platform Compared with a Standard Image Viewer and Histopathology.

Journal of nuclear medicine : official publication, Society of Nuclear Medicine·2025
Same author

Use of staging in intermediate-risk prostate cancer: A real-world data analysis.

Urologic oncology·2025
Same author

Best Systemic Therapy With or Without Radical Prostatectomy in the Management of Men With Oligometastatic Prostate Cancer: The RAMPP Randomised Controlled Trial.

European urology·2025
Same journal

Transperineal Versus Transrectal Magnetic Resonance Imaging-targeted Prostate Biopsy in the Era of Lesion-focused Sampling.

European urology focus·2026
Same journal

Should Male Pattern Baldness Be Considered in Prostate Cancer Risk Assessment? A Systematic Review and Meta-analysis.

European urology focus·2026
Same journal

A Core Outcome Set for Localized Renal Cell Cancer (L-RCC-COS).

European urology focus·2026
Same journal

Reply to Emre Karabay's Letter to the Editor re: Ritter Manuel, Stein Johannes, Barber Neil, et al. WATER III: A Prospective, Partially Randomized Trial of Aquablation Therapy Versus Transurethral Laser Enucleation of the Prostate for Treatment of Lower Urinary Tract Symptoms. Eur Urol Focus 2026;12:266-74.

European urology focus·2026
Same journal

Radioligand Therapy for Prostate Cancer - A Clinical Consultation Guide.

European urology focus·2026
Same journal

Postoperative Pelvic Lymph Node Radiation Therapy in Lymph Node-Positive Prostate Cancer and Mortality Risk.

European urology focus·2026
See all related articles

Related Experiment Video

Updated: Feb 26, 2026

A Cognitive Fusion-guided Prostate Biopsy Using Multiparametric Magnetic Resonance Imaging and Transrectal Ultrasound
06:08

A Cognitive Fusion-guided Prostate Biopsy Using Multiparametric Magnetic Resonance Imaging and Transrectal Ultrasound

Published on: March 21, 2025

1.7K

Imaging for Prostate Cancer Recurrence.

Tobias Maurer1, Matthias Eiber2, Stefano Fanti3

  • 1Department of Urology, Technische Universität München, Klinikum rechts der Isar, Munich, Germany.

European Urology Focus
|July 21, 2017
PubMed
Summary
This summary is machine-generated.

Accurate imaging is vital for recurrent prostate cancer (PCa) treatment decisions. While standard methods like CT, MRI, and bone scans are used, advanced PET scans show promise for better visualization of metastatic lesions.

Keywords:
Bone scintigraphyCTCholineMRIPETPSMAProstate cancer

More Related Videos

A New Technique for Treating Low-risk Prostate Cancer—Super Active Surveillance
05:19

A New Technique for Treating Low-risk Prostate Cancer—Super Active Surveillance

Published on: November 7, 2025

930
Use of MRI-ultrasound Fusion to Achieve Targeted Prostate Biopsy
09:11

Use of MRI-ultrasound Fusion to Achieve Targeted Prostate Biopsy

Published on: April 9, 2019

22.6K

Related Experiment Videos

Last Updated: Feb 26, 2026

A Cognitive Fusion-guided Prostate Biopsy Using Multiparametric Magnetic Resonance Imaging and Transrectal Ultrasound
06:08

A Cognitive Fusion-guided Prostate Biopsy Using Multiparametric Magnetic Resonance Imaging and Transrectal Ultrasound

Published on: March 21, 2025

1.7K
A New Technique for Treating Low-risk Prostate Cancer—Super Active Surveillance
05:19

A New Technique for Treating Low-risk Prostate Cancer—Super Active Surveillance

Published on: November 7, 2025

930
Use of MRI-ultrasound Fusion to Achieve Targeted Prostate Biopsy
09:11

Use of MRI-ultrasound Fusion to Achieve Targeted Prostate Biopsy

Published on: April 9, 2019

22.6K

Area of Science:

  • Oncology
  • Radiology
  • Medical Imaging

Background:

  • Accurate identification of metastatic sites in recurrent prostate cancer (PCa) is critical for guiding treatment decisions.
  • Current imaging procedures play a pivotal role in managing recurrent PCa.

Purpose of the Study:

  • To provide a comprehensive overview of current imaging procedures for recurrent prostate cancer (PCa).
  • To evaluate the performance of various imaging modalities in detecting recurrent PCa.

Main Methods:

  • A Medline search via PubMed was conducted using keywords related to imaging and recurrent prostate cancer.
  • Literature from 2010 to the present was prioritized, excluding non-English publications.
  • Relevant abstracts and full-text articles were reviewed for content on imaging techniques and their efficacy.

Main Results:

  • A significant lack of prospective studies and histological validation exists for newer imaging technologies like PET in recurrent PCa.
  • Heterogeneity in patient cohorts, lack of standardized assessment, and diverging endpoints hinder direct comparison of imaging modalities.
  • Current evidence for imaging in recurrent PCa is primarily descriptive.

Conclusions:

  • Computed tomography (CT), magnetic resonance imaging (MRI), and bone scintigraphy remain the standard for recurrent PCa imaging.
  • Multiparametric MRI is valuable for detecting local recurrence.
  • Positron emission tomography (PET) with choline or prostate-specific membrane antigen (PSMA) tracers may enhance visualization of metastatic lesions, requiring prospective validation.